Arteris (AIP) to Release Earnings on Tuesday

Arteris (NASDAQ:AIP) is expected to release its Q3 2025 results after the market closes on Tuesday, November 4th. Analysts expect Arteris to post earnings of ($0.11) per share and revenue of $17.00 million for the quarter. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS.Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Tuesday, November 4, 2025 at 4:30 PM ET.

Arteris (NASDAQ:AIP) last released its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.11). The firm had revenue of $16.50 million during the quarter, compared to analyst estimates of $16.35 million. Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. On average, analysts expect Arteris to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Arteris Price Performance

Arteris stock opened at $13.61 on Monday. The firm has a market cap of $580.47 million, a price-to-earnings ratio of -16.60 and a beta of 1.49. Arteris has a fifty-two week low of $5.46 and a fifty-two week high of $14.88. The firm has a fifty day moving average price of $11.15 and a two-hundred day moving average price of $9.40.

Insiders Place Their Bets

In related news, VP Paul L. Alpern sold 4,750 shares of the company’s stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $11.08, for a total value of $52,630.00. Following the sale, the vice president owned 65,960 shares of the company’s stock, valued at $730,836.80. The trade was a 6.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, COO Laurent R. Moll sold 17,200 shares of the company’s stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $12.66, for a total transaction of $217,752.00. Following the completion of the sale, the chief operating officer directly owned 343,885 shares in the company, valued at approximately $4,353,584.10. The trade was a 4.76% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 769,244 shares of company stock valued at $9,673,520 over the last 90 days. Company insiders own 33.70% of the company’s stock.

Institutional Trading of Arteris

Large investors have recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new position in shares of Arteris during the second quarter worth approximately $32,000. Strs Ohio acquired a new position in Arteris in the first quarter valued at approximately $104,000. Rhumbline Advisers lifted its holdings in Arteris by 35.8% in the second quarter. Rhumbline Advisers now owns 54,416 shares of the company’s stock valued at $519,000 after buying an additional 14,350 shares during the period. Bank of America Corp DE lifted its holdings in Arteris by 11.8% in the second quarter. Bank of America Corp DE now owns 57,093 shares of the company’s stock valued at $544,000 after buying an additional 6,008 shares during the period. Finally, Ameriprise Financial Inc. acquired a new position in Arteris in the second quarter valued at approximately $742,000. 64.36% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on AIP shares. TD Cowen upped their price objective on shares of Arteris from $12.00 to $15.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, October 8th. Jefferies Financial Group raised shares of Arteris to a “hold” rating in a research report on Tuesday, October 28th. Finally, Wall Street Zen raised shares of Arteris from a “sell” rating to a “hold” rating in a research report on Monday, September 15th. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Arteris has an average rating of “Hold” and a consensus target price of $15.00.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.